Related Experiment Video
Updated: Jun 25, 2026
07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Identification of differentially expressed genes in papillary thyroid cancers
Ki-Young Lee1, Song Mei Huang, Shengjin Li
1Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Yonsei Medical Journal
|March 5, 2009
Summary
Researchers identified two novel differentially expressed genes (DEGs), DC-STAMP and type I collagen A1, in papillary thyroid cancer (PTC) using the Genefishing technique. These findings offer insights into thyroid cancer development.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Identifying differentially expressed genes (DEGs) is crucial in tumor pathology.
- The Genefishing technique, utilizing the annealing control primer (ACP) system, is a novel method for screening DEG transcripts.
Purpose of the Study:
- To identify DEGs in papillary thyroid cancer (PTC) using the Genefishing technique.
- To explore novel molecular markers associated with PTC development.
Main Methods:
- The Genefishing technique, a new differential display method, was employed.
- Gene expression profiles were analyzed in 21 PTC cases compared to normal thyroid tissue.
Main Results:
- 17 DEGs were detected in PTCs.
- Two DEGs, DC-STAMP and type I collagen A1, were identified and confirmed by RT-PCR in 81% of cases.
- These two genes represent novel findings in PTC.
Conclusions:
- The Genefishing technique successfully identified DC-STAMP and type I collagen A1 as DEGs in PTC.
- These genes may offer insights into the mechanisms of thyroid cancer carcinogenesis and progression.